Does LOPINAVIR Cause Hepatic cytolysis? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Hepatic cytolysis have been filed in association with LOPINAVIR (Kaletra). This represents 3.0% of all adverse event reports for LOPINAVIR.
37
Reports of Hepatic cytolysis with LOPINAVIR
3.0%
of all LOPINAVIR reports
33
Deaths
36
Hospitalizations
How Dangerous Is Hepatic cytolysis From LOPINAVIR?
Of the 37 reports, 33 (89.2%) resulted in death, 36 (97.3%) required hospitalization, and 3 (8.1%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOPINAVIR. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does LOPINAVIR Cause?
Foetal exposure during pregnancy (244)
Exposure during pregnancy (184)
Virologic failure (170)
Drug resistance (134)
Off label use (133)
Lipodystrophy acquired (126)
Premature baby (107)
Diplopia (89)
Treatment failure (89)
Premature delivery (88)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which LOPINAVIR Alternatives Have Lower Hepatic cytolysis Risk?
LOPINAVIR vs LOPINAVIR\RITONAVIR
LOPINAVIR vs LOPRAZOLAM
LOPINAVIR vs LORATADINE
LOPINAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR vs LORAZEPAM